To get an emerging markets exposure do you need to necessarily invest in companies in these countries? What if some of the companies in these markets are exporters (therefore, connected more to global economy rather than local) or have a significant/increasing revenue base outside their home markets?
Conversely, a company in Germany or US may have more revenues coming in from their sales in emerging market countries rather than their own country.
Here is an interesting insight from a pension investors magazine on emerging market investing:
http://www.ipe.com/magazine/enter-the-global-dimension_33895.php?issue=
01 Feb 2010
Enter the global dimension
There  is no rule that says emerging market securities are the only – or even  the best – source of emerging market exposure. Martin Steward looks at  access points closer to home
We all know that we want  exposure to emerging markets. But what exactly does that mean? Buying a  Chinese widget manufacturer – even if those widgets are sold to  Europeans? What about a British mining company selling copper to that  manufacturer? Or a German cement maker selling to the Chinese  government? Or should we really be focused on Danish brewers selling  beer to Kenyans, or Spanish banks selling mortgages to Brazilians? And  doesn’t a European manufacturer selling to Europeans but outsourcing  costs to India offer a kind of emerging market exposure, too?
“We live in a globalised world,” observes Thomas Beevers,  pan-European equities manager at Newton Investment Management. “There  are plenty of globally-competitive companies in Europe. The country of  incorporation or listing is less important.” 
Recent Morgan Stanley research suggests that European companies now  source 23% of their revenues from emerging markets – almost doubling in a  decade. By contrast, sales to North America represent 16% and falling,  while sales within developed Europe have also fallen. Go to stock  markets like Finland’s, Austria’s, Sweden’s or Spain’s (while  underweighting Belgium’s Ireland’s and the Netherlands) and you  concentrate that effect – they all get more than 30% of revenues from  emerging markets.
But there are revenues and there are revenues.  That British mining company selling to the Chinese manufacturer selling  to the European consumer offers European economic exposure, ultimately.  The consumer is not the be-all-and- end-all. Firms like Cairn Energy and  Vedanta are clearly selling into the emerging market infrastructure  boom as well as to Chinese exporters. And as L&G Investment  Management equity strategist Georgina Taylor points out, if they sell to  a low-cost Chinese manufacturer they are likely to benefit from that  manufacturer’s growing market share against the US manufacturer that  patronises their less globalised competitors – so even that is a  distinct emerging markets exposure of sorts.
But if by emerging  market exposure we mean exposure to emerging market growth, there is no  doubt that the consumer is – or will be – the purest form of that  growth. “That’s why we prefer to target consumer staples, generally, and  beverages and tobacco in particular,” says Charles Dautresme, a  strategist with AXA Investment Managers, who reveals that his sales  force in Hong Kong is designing “a Europe fund with emerging market  exposure”.
However, while there are consumer  businesses like SABMiller and British American Tobacco that are  successful in emerging markets, very few source more than half their  revenues there. Morgan Stanley’s ranking of the top 50 European  companies by emerging market revenues put seven energy and mining  companies in its top 10 (the other three were banks). Swedish cosmetics  firm Oriflame came in at number 11, but most of its exposure is to  emerging Europe rather than the action-packed markets of Latin America  and Asia.

Regionally things look better. IT and materials dominate  European companies selling into Asia. Morgan Stanley’s China-specific  top 50 contains no less than 43 industrial, materials and consumer  discretionary stocks (with the latter being mostly auto and luxury goods  makers). So there is little day-to-day consumer exposure, and it is  difficult to tell how much of the final demand for the industrial and  materials companies is really Chinese. But the top 50 sellers into Latin  America sees cyclical exposures like materials and consumer  discretionary balanced much more by staples, utilities, telecoms and  healthcare (see figure 1).

Portugal Telecom and Endesa both make the top 10. This  is no doubt why a concentrated, cap-weighted basket of the Latin America  top 15 exhibits lower volatility than all the other sources of revenue –  even lower than an equally-weighted basket of the global emerging  market top 50 (see figure 2).
So it is possible to get that exposure in Europe. Is it desirable?  Comparing the valuations of developed market stocks selling into  emerging markets with their local equivalents, the story seems clear.  Dautresme put a basket of 74 European names together for his colleagues  in Hong Kong and found that its trailing P/E of 15 times compares well  with the MSCI Europe index (19 times), let alone MSCI Emerging Markets  (21 times). In the consumer sector this is magnified: Indonesia’s  Indofoods trades at 47 times, making Danone (42% of revenues from  emerging markets) look like a snip at 15 times. The steady stream of  IPOs is changing things, but emerging stock markets remain tilted away  from consumers and towards materials, energy and banks. “That means many  consumer-facing companies in emerging markets attract a scarcity  premium,” says Richard Turnill, head of global equity at BlackRock.
Furthermore,  many argue that global companies (with their long track records and  high corporate governance standards in shareholder-friendly cultures  with robust legal frameworks and international accounting standards) are  better positioned to tap into this growing consumer base. “Part of  joining the aspiring middle class is wanting to buy branded goods, after  all,” says Turnill. The consumer discretionary names that have made it  in China are the likes of BMW, Audi, Peugeot, Swatch, Bulgari and  Burberry. This is high-end stuff right now, “but as the Chinese consumer  moves above the $6,000 per annum mark, brand aspiration may start to go  through food products as well,” suggests Dautresme.
The beverages sector, especially SABMiller, has shown the way. Ann  Gilpin, a senior stock analyst and consumer sector specialist at  Morningstar, relates how the Brown-Forman Corporation’s advertising for  Jack Daniels in China emphasises themes of modernity and sophistication –  a million miles away from the posters we see in European metro  stations, showing pensive old blokes sitting about on rickety chairs.  “Being rural is not something one aspires to in China,” she observes.  She also singles out Avon as a very different unexpected play on  emerging market demand – its direct-selling model seems outmoded in its  home market but in Brazil, where not everyone has access to department  stores or online shopping, it is “huge”. Sweden’s Oriflame is an  interesting European equivalent.
Moreover, the marketing,  distribution and infrastructure needed to tap into these consumers can  be capital intensive, while margins can be relatively small. “Nigeria is  right at the top of the key markets for Guinness already,” says Gilpin.  “Part of that is the brand, but it’s also about Diageo’s huge war chest  dominating the smaller players. They take the cash they’re generating  from the huge, but non-growing US market and invest it in emerging  markets.”
This interesting angle takes what might be perceived as a weakness –  only a fraction of these revenues come from emerging markets – and turns  it into a positive. European consumers may not be gorging on credit  cards anymore, but their consumption is at least entrenched and stable.
Taking  the long view is important. China is the glittering prize, and while  Morgan Stanley estimates that European companies’ Asian revenues are  rising faster than those from other emerging markets, as we have seen,  Latin America’s consumers are easier to crack than China’s. Consumption  represents less than 30% of China’s economy and extensions of the social  safety net that might change the savings mentality are a long-term  project. The artificially depressed yuan is great for the exporter but  inflationary for Mr and Mrs Li. “When I ask people living in China  whether keeping growth at 8.5% is more important to the authorities than  diversifying that growth, they tell me that all they care about is the  8.5%,” says Taylor at L&G. “That suggests they’re not focused on  moving away from exports.”
Cracking the Chinese consumer will be a struggle culturally, too. One  of the reasons Brazil has been ‘emerging’ for much longer than China is  that US and European corporates have been working fairly happily there  for decades (while they have “only recently become comfortable about  protecting intellectual property rights within the Asia growth context”,  observes Aviva Investors’ CIO Niall Paul), and their brands translate  readily into that context. “Countries as huge as China will develop  their own brands and national champions,” warns Aviva Investors’ head of  European equities John Botham, “it won’t be just about NestlĂ© and  Diageo.”
That’s debatable – Western corporate marketing’s power  over a new middle class shouldn’t be underestimated – but it does appear  that China’s authorities will put up resistance. Avon had to open shops  because direct selling was prohibited until 2005. SABMiller has done  well there through a joint venture, but Coca Cola’s acquisition of  Huiyuan Juice was blocked by the ministry of commerce and Danone got a  bloody nose from its JV with Wahaha, ending in 2009 after years of  acrimonious accusations of fraud.
“The Chinese have shown that  they will make global companies fight to enter their consumer staples  market,” says Dautresme. “It’s more likely that we’ll see Chinese  companies trying to buy European companies.” Of course, buying the  under-valued European acquisition target is potentially yet another type  of emerging market exposure – not that France would ever allow a  takeover of Danone.
All of this begins to delineate the two stories of emerging market  exposure: already-happening beta and forward-looking alpha themes. “For  instant gratification the companies selling into the infrastructure boom  are seeing earnings coming through right now,” says Taylor. “Gaining  consumer market share will be a slow burn.”
Morgan Stanley  identified one in five European companies with major expansion plans in  China. Some will be SABMillers, some Cokes. Even sources of current  revenues are difficult to pin down with publicly available information  (much of the Morgan Stanley research quoted here is analysts’ best  guesses), so extrapolating earnings out over years is a true  stockpicker’s game. As Beevers at Newton suggests, that can be about  recognising the role that private healthcare will play in the lifestyles  of new middle classes, and then identifying that Novo Nordisk, for  example, already has a growing insulin-production franchise in Asia. It  can be about recognising that, while “emerging markets sounds like an  attractive theme”, as Pioneer Investment’s head of European equity  Andrew Arbuthnott reminds us, “we also have to look for business models  where the trade off between valuations and future growth stand up”.
It can even be about assessing the relative quality of a European  firm’s domestic revenues, which will provide the free cashflow to fund  emerging market expansion. 
“Just buying emerging market exposure is unlikely to work as well as it  has in the past, simply because that story is now so widely accepted,”  says BlackRock’s Turnill. “The stocks to own are the ones that can  surprise by taking market share with a winning strategy.” That is a  simple but important observation: stockpicking alpha is about  stockpicking. “There are an awful lot of companies in emerging markets  whose business models simply can’t be duplicated by other,  developed-market companies,” he reminds us.
The same applies vice  versa, as we have seen. Which takes us back to our starting point: the  best emerging market exposure is not about emerging market companies or  developed market companies, but about the best truly global companies.